JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma

Journal: Nature Communications

Published: 2019-07-25

DOI: 10.1038/s41467-019-11132-w

Affiliations: 21

Authors: 31

Go to article
Institutions Share
Children's Cancer Institute Australia (CCIA), Australia 0.38
Department of Pharmacy and Biotechnology, UNIBO, Italy 0.10
School of Biomedical Sciences and Pharmacy, UON, Australia 0.06
University Hospital of Cologne, Germany 0.06
Institute of Molecular Medicine, MLU, Germany 0.06
Institute of Cardiovascular Disease of Integrated Traditional Chinese and Western Medicine at Shanghai Shuguang Hospital, SHUTCM, China 0.06
School of Pharmacy, SHUTCM, China 0.06
The Second Affiliated Hospital of Soochow University, China 0.03
Lowy Cancer Research Centre, Australia 0.03
Bosch Institute, USYD, Australia 0.02
Central Clinical School (CCS), USYD, Australia 0.02
Kids Cancer Centre, Sydney Children's Hospitals Network, Australia 0.02
School of Biomedical Sciences, HKU, China 0.02
Children's Medical Research Institute (CMRI), Australia 0.01
Faculty of Medicine and Health, USYD, Australia 0.01
Centre for Childhood Cancer Research, UNSW Sydney, Australia 0.01
Faculty of Medicine, UNSW Sydney, Australia 0.01
School of Science and Health (SSH), Western Sydney University, Australia 0.01
Division of Hematology/Oncology, BCH, United States of America (USA) 0.01
Dana-Farber Cancer Institute (DFCI), United States of America (USA) 0.01
Harvard Department of Pediatrics, United States of America (USA) 0.01